U.S. Markets close in 25 mins.

STAAR Surgical Company (STAA)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
10.85+0.20 (+1.88%)
As of 3:33PM EDT. Market open.
People also watch
SPNCELGXRTIXIRIXSTXS

STAAR Surgical Company

1911 Walker Avenue
Monrovia, CA 91016
United States
626-303-7902
http://www.staar.com

SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees336

Key Executives

NameTitlePayExercisedAge
Ms. Caren L. MasonChief Exec. Officer, Pres and Director761.89kN/A63
Dr. Keith HollidayChief Technology Officer and VP444.07kN/A54
Mr. Samuel J. Gesten J.D.Chief Legal Officer, VP of Bus. Devel. and Corp. Sec.439.24kN/A55
Mr. Hans-Martin BlickensdoerferSr. VP of Commercial Operations - EMEA, LATAM and China407.92k143.73k52
Ms. Deborah AndrewsInterim Chief Financial OfficerN/AN/A60
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers minimally invasive intraocular lenses (IOLs), including foldable IOLs for use in minimally invasive cataract surgical procedures; aspheric IOLs that produce a clearer image than traditional spherical lenses; and nanoFLEX IOL, a single piece collamer aspheric optic, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices; and manufactures AquaFlow devices for the treatment of glaucoma. It markets its products to health care providers, including ophthalmic surgeons, vision centers, surgical centers, hospitals, government facilities, and distributors primarily under the STAAR, EVO Visian ICL, Evolution in Visual Freedom, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, Afinity, and AquaFLOW trademarks. The company sells products directly through its sales representatives in the United States, Japan, Spain, Germany, Canada, and the United Kingdom, as well as through independent distributors in approximately 60 countries. STAAR Surgical Company was founded in 1982 and is headquartered in Monrovia, California.

Corporate Governance

STAAR Surgical Company’s ISS Governance QualityScore as of June 2, 2017 is 5. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 5; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.